Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis
Abstract Background Pneumococcal meningitis is associated with high mortality and morbidity rates. Up to 50% of survivors show neurologic sequelae including hearing loss, cognitive impairments and learning disabilities, being particularly detrimental in affected infants and children where adjuvant t...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-08-01
|
| Series: | Journal of Neuroinflammation |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12974-018-1272-8 |
| _version_ | 1818535709884022784 |
|---|---|
| author | Lukas Muri Denis Grandgirard Michelle Buri Michael Perny Stephen L. Leib |
| author_facet | Lukas Muri Denis Grandgirard Michelle Buri Michael Perny Stephen L. Leib |
| author_sort | Lukas Muri |
| collection | DOAJ |
| description | Abstract Background Pneumococcal meningitis is associated with high mortality and morbidity rates. Up to 50% of survivors show neurologic sequelae including hearing loss, cognitive impairments and learning disabilities, being particularly detrimental in affected infants and children where adjuvant therapy with dexamethasone has no proven beneficial effect. We evaluated the effect of concomitantly targeting specific pathophysiological mechanisms responsible for brain damage—i.e. matrix-metalloproteinase (MMP) activity and the exacerbated cerebral inflammation provoked through antibiotic-induced bacterial lysis. Here, we combined adjunctive therapies previously shown to be neuroprotective when used as single adjuvant therapies. Methods Eleven-day-old Wistar rats were infected intracisternally with 6.44 ± 2.17 × 103 CFU Streptococcus pneumoniae and randomised for treatment with ceftriaxone combined with (a) single adjuvant therapy with daptomycin (n = 24), (b) single adjuvant therapy with Trocade (n = 24), (c) combined adjuvant therapy (n = 66) consisting of daptomycin and Trocade, or (d) ceftriaxone monotherapy (n = 42). Clinical parameters and inflammatory CSF cytokine levels were determined during acute meningitis. Cortical damage and hippocampal apoptosis were assessed 42 h after infection. Morris water maze and auditory brainstem responses were used to assess neurofunctional outcome 3 weeks after infection. Results We found significantly reduced apoptosis in the hippocampal subgranular zone in infant rats receiving adjuvant Trocade (p < 0.01) or combined adjuvant therapy (p < 0.001). Cortical necrosis was significantly reduced in rats treated with adjuvant daptomycin (p < 0.05) or combined adjuvant therapy (p < 0.05) compared to ceftriaxone monotherapy. Six hours after treatment initiation, CSF cytokine levels were significantly reduced for TNF-α (p < 0.01), IL-1β (p < 0.01), IL-6 (p < 0.001) and IL-10 (p < 0.01) in animals receiving combined adjuvant intervention compared to ceftriaxone monotherapy. Importantly, combined adjuvant therapy significantly improved learning and memory performance in infected animals and reduced hearing loss (77.14 dB vs 60.92 dB, p < 0.05) by preserving low frequency hearing capacity, compared to ceftriaxone monotherapy. Conclusion Combined adjuvant therapy with the non-bacteriolytic antibiotic daptomycin and the MMP inhibitor Trocade integrates the neuroprotective effects of both single adjuvants in experimental paediatric pneumococcal meningitis by reducing neuroinflammation and brain damage, thereby improving neurofunctional outcome. This strategy represents a promising therapeutic option to improve the outcome of paediatric patients suffering from pneumococcal meningitis. |
| first_indexed | 2024-12-11T18:28:32Z |
| format | Article |
| id | doaj.art-25e5682741d24ded875b64f39669b8e3 |
| institution | Directory Open Access Journal |
| issn | 1742-2094 |
| language | English |
| last_indexed | 2024-12-11T18:28:32Z |
| publishDate | 2018-08-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Neuroinflammation |
| spelling | doaj.art-25e5682741d24ded875b64f39669b8e32022-12-22T00:55:00ZengBMCJournal of Neuroinflammation1742-20942018-08-0115111410.1186/s12974-018-1272-8Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitisLukas Muri0Denis Grandgirard1Michelle Buri2Michael Perny3Stephen L. Leib4Neuroinfection Laboratory, Institute for Infectious Diseases, University of BernNeuroinfection Laboratory, Institute for Infectious Diseases, University of BernNeuroinfection Laboratory, Institute for Infectious Diseases, University of BernNeuroinfection Laboratory, Institute for Infectious Diseases, University of BernNeuroinfection Laboratory, Institute for Infectious Diseases, University of BernAbstract Background Pneumococcal meningitis is associated with high mortality and morbidity rates. Up to 50% of survivors show neurologic sequelae including hearing loss, cognitive impairments and learning disabilities, being particularly detrimental in affected infants and children where adjuvant therapy with dexamethasone has no proven beneficial effect. We evaluated the effect of concomitantly targeting specific pathophysiological mechanisms responsible for brain damage—i.e. matrix-metalloproteinase (MMP) activity and the exacerbated cerebral inflammation provoked through antibiotic-induced bacterial lysis. Here, we combined adjunctive therapies previously shown to be neuroprotective when used as single adjuvant therapies. Methods Eleven-day-old Wistar rats were infected intracisternally with 6.44 ± 2.17 × 103 CFU Streptococcus pneumoniae and randomised for treatment with ceftriaxone combined with (a) single adjuvant therapy with daptomycin (n = 24), (b) single adjuvant therapy with Trocade (n = 24), (c) combined adjuvant therapy (n = 66) consisting of daptomycin and Trocade, or (d) ceftriaxone monotherapy (n = 42). Clinical parameters and inflammatory CSF cytokine levels were determined during acute meningitis. Cortical damage and hippocampal apoptosis were assessed 42 h after infection. Morris water maze and auditory brainstem responses were used to assess neurofunctional outcome 3 weeks after infection. Results We found significantly reduced apoptosis in the hippocampal subgranular zone in infant rats receiving adjuvant Trocade (p < 0.01) or combined adjuvant therapy (p < 0.001). Cortical necrosis was significantly reduced in rats treated with adjuvant daptomycin (p < 0.05) or combined adjuvant therapy (p < 0.05) compared to ceftriaxone monotherapy. Six hours after treatment initiation, CSF cytokine levels were significantly reduced for TNF-α (p < 0.01), IL-1β (p < 0.01), IL-6 (p < 0.001) and IL-10 (p < 0.01) in animals receiving combined adjuvant intervention compared to ceftriaxone monotherapy. Importantly, combined adjuvant therapy significantly improved learning and memory performance in infected animals and reduced hearing loss (77.14 dB vs 60.92 dB, p < 0.05) by preserving low frequency hearing capacity, compared to ceftriaxone monotherapy. Conclusion Combined adjuvant therapy with the non-bacteriolytic antibiotic daptomycin and the MMP inhibitor Trocade integrates the neuroprotective effects of both single adjuvants in experimental paediatric pneumococcal meningitis by reducing neuroinflammation and brain damage, thereby improving neurofunctional outcome. This strategy represents a promising therapeutic option to improve the outcome of paediatric patients suffering from pneumococcal meningitis.http://link.springer.com/article/10.1186/s12974-018-1272-8Pneumococcal meningitisBrain injuryNeurologic sequelaeNeuroinflammationHearing lossCombined adjuvant therapy |
| spellingShingle | Lukas Muri Denis Grandgirard Michelle Buri Michael Perny Stephen L. Leib Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis Journal of Neuroinflammation Pneumococcal meningitis Brain injury Neurologic sequelae Neuroinflammation Hearing loss Combined adjuvant therapy |
| title | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| title_full | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| title_fullStr | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| title_full_unstemmed | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| title_short | Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis |
| title_sort | combined effect of non bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning memory and hearing function in experimental paediatric pneumococcal meningitis |
| topic | Pneumococcal meningitis Brain injury Neurologic sequelae Neuroinflammation Hearing loss Combined adjuvant therapy |
| url | http://link.springer.com/article/10.1186/s12974-018-1272-8 |
| work_keys_str_mv | AT lukasmuri combinedeffectofnonbacteriolyticantibioticandinhibitionofmatrixmetalloproteinasespreventsbraininjuryandpreserveslearningmemoryandhearingfunctioninexperimentalpaediatricpneumococcalmeningitis AT denisgrandgirard combinedeffectofnonbacteriolyticantibioticandinhibitionofmatrixmetalloproteinasespreventsbraininjuryandpreserveslearningmemoryandhearingfunctioninexperimentalpaediatricpneumococcalmeningitis AT michelleburi combinedeffectofnonbacteriolyticantibioticandinhibitionofmatrixmetalloproteinasespreventsbraininjuryandpreserveslearningmemoryandhearingfunctioninexperimentalpaediatricpneumococcalmeningitis AT michaelperny combinedeffectofnonbacteriolyticantibioticandinhibitionofmatrixmetalloproteinasespreventsbraininjuryandpreserveslearningmemoryandhearingfunctioninexperimentalpaediatricpneumococcalmeningitis AT stephenlleib combinedeffectofnonbacteriolyticantibioticandinhibitionofmatrixmetalloproteinasespreventsbraininjuryandpreserveslearningmemoryandhearingfunctioninexperimentalpaediatricpneumococcalmeningitis |